The Patent Finder

Cardax Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Cardax Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Cardax Pharmaceuticals, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,247,752Methods for the synthesis of astaxanthin
Formerly held
Term ended
Term ended Oct 3, 2025 · USPTO record
Term endedTerm ended Oct 3, 2025USPTO record
US 7,521,584Carotenoid analogs or derivatives for the inhibition and amelioration of disease
Formerly held
Term ended
Term ended May 27, 2024 · USPTO record
Term endedTerm ended May 27, 2024USPTO record
US 7,320,997Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease
Formerly held
Term ended
Term ended Jan 4, 2024 · USPTO record
Term endedTerm ended Jan 4, 2024USPTO record
US 8,063,101Carotenoid analogs and derivatives for the prevention of platelet aggregation
Formerly held
Lapsed on the fee record
Ended Nov 22, 2023 · USPTO record
Lapsed on the fee recordEnded Nov 22, 2023USPTO record
US 9,180,111Reduction in complement activation and inflammation during tissue injury by carotenoids, carotenoid analogs, or derivatives thereof
Formerly held
Lapsed on the fee record
Ended Nov 10, 2023 · USPTO record
Lapsed on the fee recordEnded Nov 10, 2023USPTO record
US 7,145,025Structural carotenoid analogs for the inhibition and amelioration of disease
Formerly held
Term ended
Term ended Oct 9, 2023 · USPTO record
Term endedTerm ended Oct 9, 2023USPTO record
US 7,317,008Carotenoid ester analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury
Formerly held
Term ended
Term ended Sep 23, 2023 · USPTO record
Term endedTerm ended Sep 23, 2023USPTO record
US 7,345,091Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
Formerly held
Term ended
Term ended Jul 29, 2023 · USPTO record
Term endedTerm ended Jul 29, 2023USPTO record
US 7,375,133Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
Formerly held
Term ended
Term ended Jul 29, 2023 · USPTO record
Term endedTerm ended Jul 29, 2023USPTO record
US 7,592,449Structural carotenoid analogs for the inhibition and amelioration of disease
Formerly held
Term ended
Ended no later than Jul 29, 2023 · USPTO record
Term endedEnded no later than Jul 29, 2023USPTO record
10 of 14 patents shown.
Pro members see all 14.
Pro members: see all 14 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited